See more : Eurofins-Cerep SA (ALECR.PA) Income Statement Analysis – Financial Results
Complete financial analysis of CanaFarma Hemp Products Corp. (CNFA.CN) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of CanaFarma Hemp Products Corp., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Fujishoji Co.,Ltd. (6257.T) Income Statement Analysis – Financial Results
- WAM Leaders Limited (WLE.AX) Income Statement Analysis – Financial Results
- Valid Soluções S.A. (VLID3.SA) Income Statement Analysis – Financial Results
- New Beginnings Acquisition Corp. (NBA-WT) Income Statement Analysis – Financial Results
- Fortuna Silver Mines Inc. (FVI.TO) Income Statement Analysis – Financial Results
CanaFarma Hemp Products Corp. (CNFA.CN)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.canafarmacorp.com
About CanaFarma Hemp Products Corp.
CanaFarma Hemp Products Corp. engages in growing, manufacturing, processing, and selling hemp oil in the United States. The company offers hemp-based products, such as chewing gum and tincture under the YOOFORIC brand. It offers its products online. The company is based in Vancouver, Canada.
| Metric | 2020 | 2019 | 2018 |
|---|---|---|---|
| Revenue | 1.78M | 56.82K | 0.00 |
| Cost of Revenue | 4.13M | 87.84K | 0.00 |
| Gross Profit | -2.35M | -31.03K | 0.00 |
| Gross Profit Ratio | -132.12% | -54.61% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 |
| General & Administrative | 3.50M | 25.86K | 6.97K |
| Selling & Marketing | 3.64M | 1.21M | -1.32 |
| SG&A | 7.14M | 1.23M | 6.96K |
| Other Expenses | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 7.74M | 1.23M | 6.96K |
| Cost & Expenses | 11.87M | 1.32M | 6.96K |
| Interest Income | 0.00 | 0.00 | 0.00 |
| Interest Expense | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 198.89K | -35.03K | 161.14K |
| EBITDA | -9.99M | -1.23M | -6.96K |
| EBITDA Ratio | -561.88% | -2,165.12% | 0.00% |
| Operating Income | -10.06M | -1.27M | -6.96K |
| Operating Income Ratio | -565.79% | -2,226.78% | 0.00% |
| Total Other Income/Expenses | -8.90M | -0.34 | 161.09K |
| Income Before Tax | -18.96M | -1.27M | -7.01K |
| Income Before Tax Ratio | -1,066.31% | -2,226.78% | 0.00% |
| Income Tax Expense | 25.00 | 25.32 | -161.14K |
| Net Income | -17.55M | -1.18M | -7.01K |
| Net Income Ratio | -986.67% | -2,070.52% | 0.00% |
| EPS | -0.12 | -0.01 | 0.00 |
| EPS Diluted | -0.12 | -0.01 | 0.00 |
| Weighted Avg Shares Out | 152.40M | 187.32M | 187.32M |
| Weighted Avg Shares Out (Dil) | 152.40M | 187.32M | 187.32M |
Source: https://incomestatements.info
Category: Stock Reports